{"nct_id":"NCT02397395","title":"An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.","status":"WITHDRAWN","status_verified_date":"2015-07","start_date":"2015-05","start_date_type":null,"primary_completion_date":"2016-02","primary_completion_date_type":"ESTIMATED","completion_date":"2016-05","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}